138 related articles for article (PubMed ID: 1397654)
1. Discovery and characterization of an HIV-1 Tat antagonist.
Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
Biochem Soc Trans; 1992 May; 20(2):525-31. PubMed ID: 1397654
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
Science; 1991 Dec; 254(5039):1799-802. PubMed ID: 1763331
[TBL] [Abstract][Full Text] [Related]
3. The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.
Cupelli LA; Hsu MC
J Virol; 1995 Apr; 69(4):2640-3. PubMed ID: 7884917
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.
Hsu MC; Dhingra U; Earley JV; Holly M; Keith D; Nalin CM; Richou AR; Schutt AD; Tam SY; Potash MJ
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6395-9. PubMed ID: 8341644
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences.
Braddock M; Cannon P; Muckenthaler M; Kingsman AJ; Kingsman SM
J Virol; 1994 Jan; 68(1):25-33. PubMed ID: 8254735
[TBL] [Abstract][Full Text] [Related]
7. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
8. 2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro.
Kira T; Hashimoto K; Baba M; Okamoto T; Shigeta S
Antiviral Res; 1996 Oct; 32(2):55-62. PubMed ID: 8891164
[TBL] [Abstract][Full Text] [Related]
9. A Tat antagonist inhibits HIV-1 induction in naturally infected and experimentally infected T cells.
Potash MJ; Bentsman G; McKinley G; Volsky DJ
Biochem Biophys Res Commun; 1992 Nov; 189(1):250-6. PubMed ID: 1449479
[TBL] [Abstract][Full Text] [Related]
10. CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.
Leung DW; Peterson PK; Weeks R; Gekker G; Chao CC; Kaplan AH; Balantac N; Tompkins C; Underiner GE; Bursten S
Proc Natl Acad Sci U S A; 1995 May; 92(11):4813-7. PubMed ID: 7761405
[TBL] [Abstract][Full Text] [Related]
11. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
Biswas DK; Tius MA; Zhuo J; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic potential of Ro 5-3335. New active benzodiazepine in vitro against HIV-1 viruses resistant or non-resistant to AZT].
Camsonne R; Bigot MC; Fusibet H; Moulin MA
Therapie; 1993; 48(2):105-7. PubMed ID: 8351676
[TBL] [Abstract][Full Text] [Related]
13. A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
Daelemans D; Schols D; Witvrouw M; Pannecouque C; Hatse S; van Dooren S; Hamy F; Klimkait T; de Clercq E; VanDamme AM
Mol Pharmacol; 2000 Jan; 57(1):116-24. PubMed ID: 10617686
[TBL] [Abstract][Full Text] [Related]
14. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
[TBL] [Abstract][Full Text] [Related]
15. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
Lee AW; Mitra D; Laurence J
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1235-42. PubMed ID: 9310291
[TBL] [Abstract][Full Text] [Related]
16. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
17. HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro-5-3335 and Ro-24-7429.
Dunne AL; Siregar H; Mills J; Crowe SM
J Leukoc Biol; 1994 Sep; 56(3):369-73. PubMed ID: 8083610
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
20. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.
Shahabuddin M; Volsky B; Hsu MC; Volsky DJ
J Virol; 1992 Nov; 66(11):6802-5. PubMed ID: 1404619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
